)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Phio Pharmaceuticals
Phio Pharmaceuticals (PHIO) investor relations material
Phio Pharmaceuticals Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary24 Feb, 2026
Value proposition and market opportunity
Targets cutaneous squamous cell carcinoma (cSCC), the second most common solid tumor, with ~1.8M annual cases and a $20B addressable market.
Current treatment regimens for cSCC are unsatisfactory, with mortality rates approaching those of melanoma.
No FDA-approved drug therapy exists for early-stage cSCC; invasive surgery is the standard of care.
PH-762 and PH-894 programs address significant unmet needs in oncology, with additional potential in autoimmune and cosmetic indications.
Technology and intellectual property
INTASYL® siRNA technology enables precise gene silencing, reactivating immune cells to kill tumor cells.
Patented asymmetric siRNA duplex design enhances specificity, stability, and delivery to target cells.
54 patents issued, with protection extending to 2044, covering chemistry, compounds, gene targets, and indications.
Platform versatility allows targeting of multiple genes relevant to oncology, autoimmune, and cosmetic applications.
Clinical development and results
PH-762 (PD-1 silencer) completed a Phase 1b dose-escalation trial in cSCC, with 22 patients treated.
Final cohort showed 85% pathological response and 100% tumor clearance in 4 of 6 responders.
No immune-related or treatment-limiting toxicities observed across five dose cohorts, even at 20-fold dose escalation.
PH-894 (BRD4 silencer) completed IND-enabling studies, showing dual action (tumor killing and immune activation) and a clean toxicology profile.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Phio Pharmaceuticals earnings date
Q4 202530 Mar, 2026
Phio Pharmaceuticals
Next Phio Pharmaceuticals earnings date
Q4 202530 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage